Healthcare Webinars

This webinar will focus on giving survivors a voice in the awareness and advocacy for antimicrobial resistance. Join us to hear inspiring stories and learn how we can work together to combat this global health threat.

The latest advancements in prophy cups, hand instruments, and handpieces help elevate the standard of care in dental hygiene. This webinar offers a comprehensive exploration of these essential tools, focusing on their evolution, new market innovations, and benefits. The benefits include superior biofilm removal, enhanced infection control, and better ergonomics. Leveraging these technologies effectively in daily practice helps with the biggest goal of all: improving patient care.

Learn why controlling your blood sugar is important, how this class can help, and have the opportunity to ask questions.

Discover a groundbreaking webinar delving into multifaceted strategies aimed at enhancing diversity within the realm of Alzheimer’s disease (AD) research. Addressing significant challenges rooted in the widespread lack of trust within diverse patient populations, the featured speakers forge collaborative efforts with advocacy groups, who serve as crucial bridges between the healthcare system and the communities they serve. Going beyond conventional screening practices, these strategies also involve extensive examination of medical records and employ a diverse array of tactics to identify potential patients who might otherwise go unnoticed. Innovation plays a pivotal role in not only tracking and reporting progress but also in educating these underrepresented patient populations. This webinar involves the open exchange of ideas, acknowledging that the path to solutions is neither instantaneous nor linear. Ultimately, this comprehensive approach encapsulates the principles of diversity, equity and inclusion (DE&I), serving as a model for advancing equitable access to Alzheimer’s research.

The development of effective vaccines is among the greatest advancements in public health to combat infectious diseases. It is a complex multi-year and multi-stakeholder process that requires well-designed strategy, partnership, and preparedness among the clinical, operational, and laboratory experts. In this webinar, hear from experts on the importance of having an integrated approach among the clinical and laboratory teams well before the protocol development and how robust laboratory and IT capabilities along with innovative automation help improve the efficiency of vaccine development.

Discover an informative webinar exploring the impact of osmolality in bioprocessing and in correlation with immunoglobulin G (IgG) production. Osmolality is described as the measurement of the contribution of all the dissolved solutes to the osmotic pressure of a solution. In biopharma, osmolality is usually used as a critical quality control check for cell culture media, buffers, and formulated drug products. It is also used as a critical process parameter during upstream cell culture and downstream filtration.The Cell Technology group at the National Institute for Bioprocessing Research and Training (NIBRT) focuses on the development of bioprocesses using mammalian cells to produce recombinant proteins, monoclonal antibodies, and viral vaccines. There is also a particular interest in the bioprocess conditions that can be used to control the biochemical structure and the post-translational modifications of glycoproteins and hence the quality of biopharmaceuticals.Osmolality is routinely used in the Cell Technology group as a QC tool, similar to the routine application in the biopharma industry. However, osmolality is applied as an experimental measurement to correlate with IgG production, nutrient depletion studies, and bioprocessing applications.In this webinar, the featured speaker will describe the impact of osmolality assessment in correlation with IgG production when examining the effect of plant protein hydrolysates as additives, in a media development project. When examining the effect of changing media composition to affect IgG glycosylation, osmolality was tracked and correlated with growth and productivity.In the investigation into the recoverability of cells at various stages of nutrient depletion, osmolality measurements were utilized to correlate the suitability of culture conditions in 're-fed' media, vs. controls of complete media. These preliminary investigations are in the process of being scaled up to the bioreactor level (bench scale) where osmolality validation will be used on samples taken in at-line process analytical technology (PAT) instrumentation development.Join this webinar to gain insights into osmolality in correlation with IgG production in a media development project.

Hi there, welcome and thank you for considering to register for this webinar! World AMR Awareness week will be celebrated this year from 18th - 24th November as it happens every year. Antimicrobial Resistance (AMR), named as one of the top 10 global health threats by World Health Organization occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents. As a result of drug resistance, antibiotics and other antimicrobial agents become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness and death. This webinar is being held as a curtain-raise and to usher our youth to World AMR Awareness Week. We appreciate and highly recognize all the great efforts, and initiatives you have prepared for the week, and we organized this webinar as part of a webinar series to help you implement the initiatives effectively, and in best practice to ensure optimal impact and for your growth too. We will learn more about basics of project management, and how to embrace skills such as; effective planning, efficient implementation, monitoring and evaluation, and project dissemination. Our esteemed guest speaker will be Mimi MELLES-BREWER, Technical Officer, Antimicrobial Resistance (AMR) AMR Awareness, and Campaigns at World Health Organization Headquarters, who has vast experience and deep expertise in engaging with the youth. Thank you, and we look forward to seeing you in the webinar! Please share with colleagues too!

Understand diabetes and the connection to Covid autoimmunity as it relates to both infection and vaccination.

Today’s pharmaceutical industry is demanding more flexibility in manufacturing. Faced with rapidly evolving patient needs and relentless pressure to bring new drugs to market fast, companies must find ways to swiftly adapt, scale and optimize their production processes. But automation systems are traditionally rigid and expensive to change. To address this growing challenge, the manufacturing facility of the future is modular, using 'plug-and-play' technology to deliver greater versatility without increasing costs or compromising quality. In this webinar, you will find out how modular production based on this groundbreaking new standard is changing the industry for the better. You will also hear from Sebastian Härtner, Lead of Future Manufacturing for Life Science and Chemicals at EMD Electronics (a division of Merck KGaA, Darmstadt, Germany). Sebastian will introduce how these flexible manufacturing practices were implemented at one facility and what they have accomplished as a result. Key learning objectives: Why pharmaceutical companies need flexibility in manufacturing, How modularity is achieved using the Module Type Package (MTP) standard from NAMUR NE 148, How a flexible approach makes planning easier for everything from physical connections to IT/OT cybersecurity, Who is already leveraging modular production, and how it is transforming their business.

Windtree Therapeutics, Inc. is advancing late-stage interventions for acute cardiovascular disorders to treat patients in moments of crisis. Using new scientific and clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate, istaroxime, being developed as a first-in-class treatment for cardiogenic shock. Windtree's heart failure platform includes follow-on oral pre-clinical SERCA2a activator assets as well. Included in Windtree's portfolio is rostafuroxin, a novel precision drug product targeting the treatment resistant hypertension disease state for patients with certain genetic profiles.